|
|
Volumn 492, Issue 7427, 2012, Pages 19-
|
|
FDA under pressure to relax drug rules
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TELAVANCIN;
TELITHROMYCIN;
VANCOMYCIN;
AMINOGLYCOSIDE;
ANTIINFECTIVE AGENT;
KETOLIDE;
DRUG APPROVAL;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
HOSPITAL ACQUIRED PNEUMONIA;
HUMAN;
LIVER FAILURE;
MEDICAL RECORD;
NOTE;
ORGANIZATION;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SKIN INFECTION;
CAUSE OF DEATH;
CLINICAL TRIAL (TOPIC);
LEGAL ASPECT;
METHODOLOGY;
STATISTICS;
UNITED STATES;
AMINOGLYCOSIDES;
ANTI-BACTERIAL AGENTS;
CAUSE OF DEATH;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
KETOLIDES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84870566968
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/492019a Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|